7.8 ARTERIAL STIFFNESS AND SYSTEMIC INFLAMMATION IN COPD PATIENTS
Background: COPD is one of the leading causes of mortality worldwide. Systemic low-grade inflammation is a common finding in COPD. Soluble urokinase-type plasminogen activator receptor (suPAR) indicates an inflammatory state and it has an association with atherosclerosis and cardiovascular disease (...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2016-11-01
|
Series: | Artery Research |
Online Access: | https://www.atlantis-press.com/article/125930422/view |
_version_ | 1811300773589417984 |
---|---|
author | Renata Marietta Bocskei Lilla Tamasi Bela Benczur Attila Cziraki Gyorgy Losonczy Aniko Bohacs |
author_facet | Renata Marietta Bocskei Lilla Tamasi Bela Benczur Attila Cziraki Gyorgy Losonczy Aniko Bohacs |
author_sort | Renata Marietta Bocskei |
collection | DOAJ |
description | Background: COPD is one of the leading causes of mortality worldwide. Systemic low-grade inflammation is a common finding in COPD. Soluble urokinase-type plasminogen activator receptor (suPAR) indicates an inflammatory state and it has an association with atherosclerosis and cardiovascular disease (CVD). ThesuPAR reflects different aspects of inflammation as high sensitive C-reactive protein (hsCRP) and IL-6. Elevated CVD risk is observed in COPD. However the correlation between COPD and arterial stiffness is rarely investigated in the literature.
We investigated the association between some inflammatory biomarkers (suPAR, IL-6, hsCRP) and arterial stiffness in COPD and control patients.
Methods: We measured 45 middle aged individuals (25 COPD and 20 control normotensive patients) without diabetes and cardiovascular disease. IL-6, hsCRP, suPAR were determined in fasting blood samples. Whole body plethysmography, assessment tests and aortic pulse wave velocity (aoPWV), augmentation index (Aix), central systolic blood pressure (cSBP) were determined. COPD patients were categorized according to GOLD-classification.
Results: Patients with COPD have a higher level of IL-6 (5.38 vs 3.63 pg/ml p=0.022), suPAR (2.84 vs 2.41 ng/ml p=0.036), and hsCRP (2.99 vs 1.91 mg/L p=0.068). The patients with COPD have a significant higher aoPWV (p=0.002), and cSBP (p=0.022).
Conclusion: In this study we found elevated inflammatory markers and aoPWV in COPD patients, both of them indicate the presence of earlier atherosclerosis than in controls without COPD. |
first_indexed | 2024-04-13T06:57:14Z |
format | Article |
id | doaj.art-af7ca37633534344b06a7fab7476e2f5 |
institution | Directory Open Access Journal |
issn | 1876-4401 |
language | English |
last_indexed | 2024-04-13T06:57:14Z |
publishDate | 2016-11-01 |
publisher | BMC |
record_format | Article |
series | Artery Research |
spelling | doaj.art-af7ca37633534344b06a7fab7476e2f52022-12-22T02:57:13ZengBMCArtery Research1876-44012016-11-011610.1016/j.artres.2016.10.0547.8 ARTERIAL STIFFNESS AND SYSTEMIC INFLAMMATION IN COPD PATIENTSRenata Marietta BocskeiLilla TamasiBela BenczurAttila CzirakiGyorgy LosonczyAniko BohacsBackground: COPD is one of the leading causes of mortality worldwide. Systemic low-grade inflammation is a common finding in COPD. Soluble urokinase-type plasminogen activator receptor (suPAR) indicates an inflammatory state and it has an association with atherosclerosis and cardiovascular disease (CVD). ThesuPAR reflects different aspects of inflammation as high sensitive C-reactive protein (hsCRP) and IL-6. Elevated CVD risk is observed in COPD. However the correlation between COPD and arterial stiffness is rarely investigated in the literature. We investigated the association between some inflammatory biomarkers (suPAR, IL-6, hsCRP) and arterial stiffness in COPD and control patients. Methods: We measured 45 middle aged individuals (25 COPD and 20 control normotensive patients) without diabetes and cardiovascular disease. IL-6, hsCRP, suPAR were determined in fasting blood samples. Whole body plethysmography, assessment tests and aortic pulse wave velocity (aoPWV), augmentation index (Aix), central systolic blood pressure (cSBP) were determined. COPD patients were categorized according to GOLD-classification. Results: Patients with COPD have a higher level of IL-6 (5.38 vs 3.63 pg/ml p=0.022), suPAR (2.84 vs 2.41 ng/ml p=0.036), and hsCRP (2.99 vs 1.91 mg/L p=0.068). The patients with COPD have a significant higher aoPWV (p=0.002), and cSBP (p=0.022). Conclusion: In this study we found elevated inflammatory markers and aoPWV in COPD patients, both of them indicate the presence of earlier atherosclerosis than in controls without COPD.https://www.atlantis-press.com/article/125930422/view |
spellingShingle | Renata Marietta Bocskei Lilla Tamasi Bela Benczur Attila Cziraki Gyorgy Losonczy Aniko Bohacs 7.8 ARTERIAL STIFFNESS AND SYSTEMIC INFLAMMATION IN COPD PATIENTS Artery Research |
title | 7.8 ARTERIAL STIFFNESS AND SYSTEMIC INFLAMMATION IN COPD PATIENTS |
title_full | 7.8 ARTERIAL STIFFNESS AND SYSTEMIC INFLAMMATION IN COPD PATIENTS |
title_fullStr | 7.8 ARTERIAL STIFFNESS AND SYSTEMIC INFLAMMATION IN COPD PATIENTS |
title_full_unstemmed | 7.8 ARTERIAL STIFFNESS AND SYSTEMIC INFLAMMATION IN COPD PATIENTS |
title_short | 7.8 ARTERIAL STIFFNESS AND SYSTEMIC INFLAMMATION IN COPD PATIENTS |
title_sort | 7 8 arterial stiffness and systemic inflammation in copd patients |
url | https://www.atlantis-press.com/article/125930422/view |
work_keys_str_mv | AT renatamariettabocskei 78arterialstiffnessandsystemicinflammationincopdpatients AT lillatamasi 78arterialstiffnessandsystemicinflammationincopdpatients AT belabenczur 78arterialstiffnessandsystemicinflammationincopdpatients AT attilacziraki 78arterialstiffnessandsystemicinflammationincopdpatients AT gyorgylosonczy 78arterialstiffnessandsystemicinflammationincopdpatients AT anikobohacs 78arterialstiffnessandsystemicinflammationincopdpatients |